Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants

Completed · Phase 1

Conditions studied: Heart Decompensation, Acute

In brief

An intravenous infusion in healthy subjects to obtain information about the absorption, metabolism, and excretion (AME) of BMS-986231

Key facts

Study ID

NCT03210909

Run by

Bristol-Myers Squibb

People needed

5

Starts

2017-06-22

Expected to finish

2017-07-20

Last updated by the study team

2017-08-01

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Signed Informed Consent
• Target population: Healthy males with no clinically significant deviations from normal in medical history, physical examinations, vital signs, electrocardiograms (ECGs), physical measurements, and clinical laboratory tests
• Body weight between 75 and 95 kg, inclusive; body mass index (BMI) between 18 to 32 kg/m2.

You may not qualify if…

• History of chronic illness
• Chronic headaches
• Recurrent dizziness
• Personal or family history of heart disease
• Personal history of bleeding diathesis
• Other protocol defined inclusion/exclusion criteria could apply

Where it is running

• Covance Clinical Research Unit — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.